Compare IDEXX Laboratories, Inc. (IDXX) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? IDEXX Laboratories, Inc. trades at $571.94 (market cap $46.22B), while ProShares UltraShort Bloomberg Natural Gas ETF trades at $28.6. The key difference: ProShares UltraShort Bloomberg Natural Gas ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | KOLD | |
|---|---|---|
Market Cap | $46.22B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $766.68 | $49.39 |
52-Week Low | $526.44 | $13.58 |
Enterprise Value | $47.12B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
KOLD, an inverse ETF tracking natural gas futures, trades at $28.34, down 1.05% on the day. Technical indicators show a bullish trend with moving averages supporting upside momentum, while oscillators remain neutral. Recent news highlights natural gas price volatility driven by weather forecasts and LNG export fluctuations, with the ETF positioned as a tactical tool for traders amid market swings.
The outlook for KOLD hinges on continued natural gas price volatility, offering short-term trading opportunities but carrying high risk due to its leveraged structure. Key risks include rapid price reversals in natural gas and macroeconomic shifts affecting energy demand, requiring careful risk management for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About ProShares UltraShort Bloomberg Natural Gas ETF
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →
